Form 4: Abbott Laboratories CEO Robert Ford Reports Stock Disposal

Abbott Laboratories CEO Robert Ford disposed of 31,610 common shares to cover tax obligations, while still holding a significant number of shares directly and indirectly through a family trust.

Summary

• On February 29, 2024, Robert B. Ford, the Chairman and CEO of Abbott Laboratories, disposed of 31,610 common shares.
• The transaction was executed at a price of $120.05 per share.
• This disposal was likely to cover tax obligations related to vesting equity.
• Following the transaction, Ford directly owns 220,059 common shares.
• Ford also indirectly owns 197,403 common shares through the Ford Family Trust DTD June 2, 2014, where he serves as co-trustee.

Sentiment

Score: 6

Explanation: The document is a standard SEC filing detailing a stock disposal. It doesn't inherently convey positive or negative sentiment, but the disposal could be perceived neutrally as part of routine financial planning.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. Disposals are not necessarily negative, and can be for tax planning or diversification.

Stakeholder Impact

• The stock disposal may have a minor impact on shareholders, potentially creating slight downward pressure on the stock price in the short term.

Key Dates